ZURICH (Reuters) – Switzerland has filed five cases of British coronavirus differentiation and two cases of South African variant, a Swiss health ministry official said on Tuesday, adding that it is expected that more cases of these faster-spreading mutations will emerge.
Patrick Mathys, director of the health ministry’s emergency management department, also said Switzerland’s supply of COVID-19 imaging will be limited until more vaccines are approved by the country’s regulator, possibly next year.
Switzerland is the latest country to record volatile cases, as country after country reports similar diseases, forcing some countries to ban travel to Britain and South Africa among others. fears that a more live virus could exacerbate tight healthcare systems.
“So far, there is no evidence that these rays are spreading in large numbers in Switzerland,” said Mathys, of the variables. “But it would be deceptive to think that these diseases, which have been confirmed in the laboratory, are the only ones in Switzerland. We have to expect to find out more, and it seems to have already been released. ”
One of the cases found in Switzerland is living in nearby France, Mathys said.
Switzerland has recorded 4,197 new infections since Monday, bringing the most since the outbreak began to 442,481, more than 5% of the population.
Another 131 people died, bringing COVID-19 deaths to 6,909.
To date Switzerland has received 107,000 doses of Pfizer vaccine and German companion BioNTech, and they are targeting sightings at former nursing home residents and medical staff.
The country expects to receive 250,000 monthly doses of the Pfizer / BioNTech vaccine, but a delivery increase beyond that is dependent on approval for additional views from Moderna and AstraZeneca now under investigation.
“We have to do with what we have, for now,” said Mathys. “We can’t do magic from thin air.”
Reporting by John Miller; edited by Brenna Hughes Neghaiwi